Ranbaxy Laboratories's Chief Executive Arun Sawhney poses for a picture at his office in Gurgaon on the outskirts of New Delhi June 13, 2013. Credit: Reuters/Adnan Abidi (Reuters) - Indian drugmaker Ranbaxy Laboratories still has exclusive ... Reuters, 1 month ago
Like Novartis before it, AstraZeneca benefits big time from Ranbaxy issues - FiercePharma, 1 month ago
Ranbaxy still has exclusive rights for Nexium generic: CEO - Economic Times, 1 month ago
2 images for "arun sawhney"
Excelsior Correspondent JAMMU, Nov 23: Independent candidate from Jammu West, Arun Sawhney, today attacked both NC and Congress for plundering public wealth openly and shamelessly. Addressing a public meeting at Bakshi Nagar, he came heavily on ...Daily Excelsior.com, 4 weeks ago
Mumbai : Drug manufacturer Ranbaxy Laboratories said that it has received regulatory approval to launch its new chemical entity (NCE) Synriam in seven African countries namely Nigeria , Uganda , Senegal , Cameroon , Guinea , Kenya and Ivory Coast .4 Traders, 5 days ago Ranbaxy gets nod to sell drug treating malaria in 7 African nations DNA India, 6 days ago
While the company has already launched the product in Uganda, it is planning to introduce the product in other six countries towards end of January 2015 BS B2B Bureau | Gurgaon December 16, 2014 Last Updated at 22:23 IST Ranbaxy Laboratories Limited ...Business Standard India, 5 days ago Ranbaxy to launch malaria drug in 7 African countries Bio Spectrum Asia, 6 days ago Ranbaxy Gets the Nod to Commence Distribution of Its Anti-malarial Drug in 7 African Countries MedIndia, 6 days ago Ranbaxy to launch India's first new chemical entity Synriam in seven African countries PharmaBiz, 1 week ago
03:30 pm Market closing Continuing its sluggish mode, the market ended flat. The Sensex was down 31.12 points at 27319.56 and the Nifty was down 4.50 points at 8219.60. About 1178 shares advanced, 1728 shares declined, and 108 shares were ...Moneycontrol.com, 1 week ago
Natco has now won appeals at all three stages, from the the Intellectual Property Appellate Board (IPAB), High Court and now, the SC The Supreme Court of India (SC) has dismissed Bayer's Special Leave Petition (SLP) against India's first ...Financial Express, 1 week ago
India,United States : CCI grants approval for SUN PHARMA and RANBAXY LABS merger [TendersInfo (India)]
The Competition Commission of India (CCI) has granted approval for the proposed merger between the Sun Pharma and Ranbaxy Labs. The merger will result in a combined entity with annual sales worth $4.3 billion, making it the fifth-largest generic ...Pharmacy Choice, 1 week ago Ranbaxy Posts Loss after Write-offs on US Import Bans International Business Times India, 1 week ago CCI approves proposed merger between Sun Pharma and Ranbaxy India Infoline, 1 week ago Ranbaxy and Sun Pharma merger approved Pharmafocus, 1 week ago
By R Sriram Sarkaar sabka mai baap hai! Whenever there is a problem, everybody goes to them for help! The head of a large finance house who made this succinct analysis many years ago could not have anticipated the current situation where a ...Economic Times, 1 week ago
Ranbaxy's Journey Ranbaxy is an India-based pharmaceutical company. Its subsidiary, Ohm Laboratories in the US, received an approval to launch a cheaper version of Novartis blood pressure and heart attack treatment pill, Diovan, from the US Food ...International Business Times India, 1 week ago Ranbaxy Q2 net profit up Individual.com, 1 month ago Pharmaceuticals Newsletter - October 27 to 31, 2014 India Infoline, 1 month ago Ranbaxy Back in Black with Rs 478 cr Profit New Indian Express, 1 month ago
NEW DELHI: Six months after Modi Sarkar assumed power amidst great expectations, many industrialists are concerned about what they see as a lack of boldness in reforms and an absence of radical ideas. As a result, they are largely unwilling to ...Times of India, 1 week ago
on your WebpageAdd Widget >Get your members hooked!